Biocon receives EIR from USFDA for its Bengaluru facility
The US Food and Drug Administration (USFDA) has sent the report citing closure of inspection of Biocon's sterile drug product manufacturing facility in Bengaluru
The US Food and Drug Administration (USFDA) has sent the report citing closure of inspection of Biocon's sterile drug product manufacturing facility in Bengaluru